FDA Inspection 730127 — Oklahoma Blood Institute

Oklahoma Blood Institute — FEI 3008629186

The FDA completed an inspection of Oklahoma Blood Institute on June 21, 2011 in Fort Smith, AR. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
June 21, 2011
Fiscal Year
2011
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Fort Smith, AR (United States)